Diadema Partners »

Gossamer Bio shares owned by Diadema Partners

Quarter-by-quarter ownership of Gossamer Bio (GOSS) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Gossamer Bio

Tip: Access up to 7 years of quarterly data

All positions including Gossamer Bio held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gossamer Bio by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.2M 825k 2.63

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Gossamer Bio

NEA Management Company
Octagon Capital Advisors
BlackRock
Vanguard Group
Arch Venture Corp
Samsara BioCapital
Palo Alto Investors
683 Capital Management
Siren
Acadian Asset Management
Hillhouse Capital Advisors
Silverarc Capital Management
Geode Capital Management
FMR
State Street Corporation

View all funds holding Gossamer Bio